Status:
COMPLETED
Effect of Nebulized Bronchodilators on Heart Rate
Lead Sponsor:
Fahim Khorfan, MD
Collaborating Sponsors:
Ascension Health
Conditions:
COPD
Sepsis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the study is to determine adverse events rates of nebulized albuterol versus levalbuterol among adult critically ill patients and determine if a differential exists in adverse events be...
Detailed Description
A randomized, single-blind, cross-over, prospective study was conducted in seventy critically ill adult patients with acute air flow obstruction. Patients were randomized to nebulized albuterol altern...
Eligibility Criteria
Inclusion
- Adults who required inhaled bronchodilator therapy in the form of short acting beta adrenergic receptor agonist and short acting anti-cholinergic treatment every 4-6 hours for respiratory functions
Exclusion
- Known allergy or sensitivity to study medications
- Baseline heart rate was greater than 110 beats per minute
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT01151579
Start Date
December 1 2008
End Date
November 1 2009
Last Update
October 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Genesys Regional Medical Center
Grand Blanc, Michigan, United States, 48439